Statistics on Biotechnology Use  
Results by sector of operation
Total sectors. Biotechnology results by main variables and fields of operation. 
Unidades: specified in variables

,Total,Units,P.A.,Higher Education,PNPI,
Units that perform R+D in Biotechnology,1.289,1.079,141,58,11,
%Units according to biotechnology used: Genetic code,44,35,91,93,55,
%Units according to biotechnology used: Functional units,51,44,82,98,46,
%Units according to biotechnology used: Cellular and tissue culturing and engineering,34,26,68,88,64,
%Units according to biotechnology used: Bioprocesses,52,49,55,91,27,
%Units according to biotechnology used: Sub-cellular organisms,16,8,47,71,36,
%Units according to biotechnology used: Bio-computing,30,23,60,86,27,
%Units according to biotechnology used: Nanobiotechnology,20,15,38,67,9,
%Units according to biotechnology used: Other,12,12,13,12,.,
Units in which biotechnology activities are:  Main and/or exclusive,571,519,40,3,9,
Units in which biotechnology activities are: A secondary line of business,260,179,41,40,.,
Units in which biotechnology activities are: A tool necessary for production,458,381,60,15,2,
%Units by field(s) of ultimate application of biotechnology use: Human health,53,48,76,93,82,
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,22,21,17,55,9,
%Units by field(s) of ultimate application of biotechnology use: Food products,34,33,24,81,9,
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:,23,22,18,69,27,
%Units by field(s) of ultimate application of biotechnology use: Environment,20,17,16,72,.,
%Units by field(s) of ultimate application of biotechnology use: Industry,17,15,12,74,.,
Personnel in R&D in biotechnology (no. of persons),34.060,9.795,12.138,11.848,279,
Personnel in R&D in biotechnology (no. of persons): Researchers,22.385,5.573,7.470,9.117,225,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,11.675,4.222,4.668,2.731,54,
Personnel in R&D in biotechnology (no. of persons): women,18.456,5.298,7.068,5.917,173,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,11.274,2.925,3.864,4.350,135,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,7.182,2.373,3.204,1.567,38,
Personnel in R&D in biotechnology (FTE),23.664,3,6.828,6,9.456,2,7.281,1,98,4,
Personnel in R&D in biotechnology (FTE): Researchers,15.134,4,4.106,5,5.437,8,5.526,3,63,8,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,8.529,9,2.722,1,4.018,4,1.754,8,34,6,
Personnel in R&D in biotechnology (FTE): women,13.233,6,3.811,7,5.622,5,3.725,74,4,
Personnel in R&D in biotechnology (FTE): (women) Researchers,7.820,7,2.190,7,2.885,9,2.699,8,44,3,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,5.412,9,1.621,2.736,6,1.025,2,30,1,
Internal expenditure on R&D (thousands of euros),1.450.426,533.826,553.526,357.077,5.998,
1) By nature of the expense: Current expenses,1.345.487,492.955,528.602,318.459,5.470,
1.1) Remuneration to researchers,612.335,203.439,207.991,198.908,1.997,
1.2) Remuneration to technicians and assistants,261.758,96.850,119.932,44.005,971,
1.3) Other current expenses,471.394,192.666,200.679,75.547,2.502,
2) By nature of the expense: Capital expenses,104.939,40.870,24.924,38.617,527,
2.1) Land and buildings,25.473,7.521,1.585,16.062,305,
2.2) Equipment and instruments,75.530,32.078,22.111,21.131,210,
2.3) Acquisition of specific R+D software,3.936,1.270,1.228,1.424,13,
1) By origin of the funds: National funds,1.280.003,432.869,510.176,331.233,5.725,
1.1) Own funds,460.825,319.046,66.029,74.512,1.238,
1.2) From companies,113.547,39.253,47.227,24.742,2.324,
1.3) Public Administration funds,675.417,70.063,379.086,225.082,1.185,
1.4) From Universities,4.236,156,3.197,819,65,
1.5) From non profit private institutions,25.979,4.351,14.637,6.078,912,
1) By origin of the funds: Foreign funds,170.423,100.956,43.351,25.843,273,
2.1) From EU programmes,77.465,20.070,36.920,20.376,99,
2.2) Other foreign funds,92.959,80.886,6.431,5.467,174,
Purchase of services R & D in Biotechnology to (thousands of euros),162.538,138.625,23.594,278,41,
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain,123.047,101.114,21.615,278,41,
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad,39.491,37.512,1.979,.,.,
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital,48,46,59,57,46,
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information,13,13,16,14,18,
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources,17,12,48,35,9,
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,16,14,21,31,9,
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,21,19,28,43,27,
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels,21,19,28,38,36,
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,18,18,18,12,18,
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,36,37,37,26,18,
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost,50,49,50,55,55,
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,19,19,21,16,18,
%Units that have requested biotechnology patents in Biotechnology,21,15,45,74,.,
Number of patents requested,1.729,466,685,578,.,
Notas:

.
'..'=data not available 

 '.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent 

 (*) Total calculated from the total number of companies with related activities  with Biotechnology and the total units from other sectors with activities  in R&D in Biotechnology
Fuente: National Statistics Institute